Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 28,2024 No.4 Detail

Identification of the compounds of Jiegu Qili tablets and constituents absorbed into blood based on UPLC-Q-Exactive-MS technology

Published on Jan. 04, 2025Total Views: 512 times Total Downloads: 64 times Download Mobile

Author: FANG Xiaoyang 1, 2 ZHOU Rongrong 3 SHEN Bingbing 1, 2 HE Weiwei 1, 2 XIAO Jie 1, 4 XU Jin 5 ZENG  Hongliang 1, 4 ZHANG Shuihan 1, 2

Affiliation: 1. Academy of Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China 2. Institute of Chinese Medicine Resources, Hunan Academy of Chinese Medicine, Changsha 410013, China 3. Center Laboratory, Affiliated Hospital of Hunan Academy of Chinese Medicine, Changsha 410006, China 4. Center of Medical Laboratory Animals, Hunan Academy of Chinese Medicine, Changsha 410013, China 5. Hunan Jinsha Pharmaceutical Co., Ltd., Changsha 410015, China

Keywords: Jiegu Qili tablets Component analysis Medicated serum Ultra performance liquid chromatography-quadrupole-exactive-mass spectrometry Chemical composition Metabolites Blood components

DOI: 10.12173/j.issn.2097-4922.202404200

Reference: FANG Xiaoyang, ZHOU Rongrong, SHEN Bingbing, HE Weiwei, XIAO Jie, XU Jin, ZENG Hongliang, ZHANG Shuihan.Identification of the compounds of Jiegu Qili tablets and constituents absorbed into blood based on UPLC-Q-Exactive-MS technology[J].Yaoxue QianYan Zazhi,2024, 28(4):605-616.DOI: 10.12173/j.issn.2097-4922.202404200.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective To conduct the qualitative analysis of the chemical composition and mobile components in rat blood of Jiegu Qili tablets using ultra performance liquid chromatography-quadrupole-exactive-mass spectrometry (UPLC-Q-Exactive-MS) technology, and to provide reference for the in vivo study of effective substances in this preparation.

Methods In vitro chromatographic condition was as follows: Hypersil GOLD C18 chromatography column (50 mm × 2.1 mm, 1.9 µm) was used, the mobile phase was 0.1% formic acid aqueous solution and methanol (gradient elution), the column temperature was 30  ℃, and the injection volume was 5  µL. In vitro mass spectrometry condition was as follows: the sample was ionized by electric spray and detected by positive and negative ion dual mode, with scanning range of m/z 100~1 500. In vivo chromatographic condition was as follows: ACQUITY HPLC HSS T3 chromatography column (100 mm×2.1 mm, 1.8 µm) was used, the mobile phase was 5% water+5% acetonitrile and 47.5% acetonitrile+47.5% isopropanol+5% water (gradient elution), the column temperature was 40 ℃, and the injection volume was 8  µL. In vivo mass spectrometry condition was as follows: the sample was ionized by electric spray and detected by positive and negative ion dual mode, with scanning range of m/z 70~1 050. SD rats were given Jiegu Qili tablets by intragastric administration for 7 days, and drug-containing serum and blank serum samples (female and male Jiegu Qili tablets serum group, and female and male blank serum group) were obtained through abdominal aorta. The non-targeted LC-MS technique and Progenesis QI software were used for comparative analysis to identify the transitional components in the blood of rats.

Results  75 compounds were identified in vitro, and 98 compounds were identified in vivo. Based on the chemical composition identified in vitro and in vivo, a total of 7 blood components were identified, including methyl isoquercetin, arachidonic acid, citric acid, pyroglutamic acid, 3-indole propionic acid, 16 hydroxypalmitic acid, and oleic acid amide.

Conclusion  This method is efficient, accurate and sensitive, and can provide scientific reference for future research on the pharmacological substance basis and quality control of Jiegu Qili tablets

Full-text
Please download the PDF version to read the full text: download
References

1. 张晓芹, 林炳锋, 刘爽, 等. 基于UHPLC-Q/TOF-MS技术鉴定青钱柳叶在大鼠体内的入血成分及代谢产物[J]. 中国现代应用药学, 2023, 40(17): 2435-2445. [Zhang XQ, Lin BF, Liu S, et. Based on UHPLC-Q/TOF-MS technology, the blood components and metabolites of Salix glauca leaves in rats were identified[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(17): 2435-2445.] DOI: 10.13748/j.cnki.issn 1007-7693.20222841.

2. Xiong H, Li N, Zhao L, et al. Integrated serum pharmacochemistry, metabolomics, and network pharmacology to reveal the material basis and mechanism of Danggui Shaoyao San in the treatment of primary dysmenorrhea[J]. Front Pharmacol, 2022, 13: 942955. DOI: 10.3389/fphar.2022.942955.

3. 孙凯, 熊辉, 杨洪军, 等. 接骨七厘片(胶囊)治疗骨折临床应用专家共识[J]. 中国中药杂志, 2023, 48(7): 1976-1981. [Sun K, Xiong H, Yang HJ, et. Expert consensus on the clinical application of seven centimeters (capsules) in the treatment of fractures[J]. China Journal of Chinese Materia Medica, 2023, 48(7): 1976-1981.] DOI: 10.19540/j.cnki.cjcmm.20221230.502.

4. 杨玮玲. 接骨七厘片联合低分子肝素钠注射液治疗腰椎骨折患者的临床疗效[J]. 医疗装备, 2022, 35(15): 111-113. [Yang WL. Clinical efficacy of Elderberry Qili tablets combined with low molecular weight heparin sodium injection in the treatment of patients with lumbar vertebral fractures[J]. Medical Equipment, 2022, 35(15): 111-113.] DOI: 10.3969/j.issn.1002-2376.2022.15.037.

5. 林社海. 接骨七厘片联合手法复位在桡骨远端骨折功能恢复中的应用效果[J]. 临床合理用药杂志, 2021, 14(6): 160-161. [Lin SH. Effect of joint slices combined with manual reduction in the functional recovery of distal radius fractures[J]. Chinese Journal of Clinical Rational Drug Use, 2021, 14(6): 160-161.] DOI: 10.15887/j.cnki.13-1389/r.2021.06.064.

6. 李彬, 李广彬. 接骨七厘片联合交锁髓内钉固定术治疗胫腓骨骨折临床研究[J]. 新中医, 2022, 54(14): 95-98. [Li B, Li GB. Clinical study of the treatment of tibia and fibular fracture by interlocking intramedullary nail fixation[J]. Journal of New Chinese Medicine, 2022, 54(14): 95-98.] DOI: 10.13457/j.cnki.jncm.2022.14.021.

7. 周美丽, 韩妮萍. 当归的有效成分及药理作用研究进展[J]. 环球中医药, 2024, 17(7): 1420-1427. [Zhou  ML, Han NP. Research progress on the active ingredients and pharmacological effects of Angelica sinensis[J]. Global Traditional Chinese Medicine, 2024, 17(7): 1420-1427.] DOI: 10.3969/j.issn.1674-1749.2024.07.038.

8. 周群, 曾弦, 黄丹, 等. 骨碎补化学成分和生物活性研究进展[J]. 世界科学技术-中医药现代化, 2021, 23(8): 2727-2741. [Zhou Q, Zeng X, Huang D, et al. Research progress on chemical composition and biological activity of bone fragmentation[J]. Institutes of Science and Development, Chinese Academy of Sciences, 2021, 23(8): 2727-2741.] DOI: 10.11842/wst.20210203004.

9. 叶琪, 苏宏娜, 杨艺, 等. 乳香有效成分治疗冠心病的作用机制研究进展[J]. 中草药, 2023, 54(16): 5379-5389. [Ye Q, Su HN, Yang Y, et al. Research progress on the mechanism of action of Frankincense active ingredient in the treatment of coronary heart disease[J]. Chinese Herbal Medicines, 2023, 54(16): 5379-5389.] DOI: 10.7501/j.issn.0253-2670.2023.16.027.

10. 曾健, 李聪, 熊磊, 等. 大黄有效成分及其药理作用研究进展[J]. 山东化工, 2024, 53(10): 135-137. [Zeng  J, Li C, Xiong L, et. Research progress on the active components of Rhubarb and its pharmacological effects[J]. Shandong Chemical Industry, 2024, 53(10): 135-137.] DOI: 10.19319/j.cnki.issn.1008-021x.2024.10.075.

11. 王潇, 文敏, 郑沛, 等. 土鳖虫化学成分和药理作用的研究进展及其质量标志物(Q-Marker)的预测分析[J]. 环球中医药, 2024, 17(5): 933-940. [Wang X, Wen M, Zheng P, et al. Research progress on chemical composition and pharmacological effects of Soil soft-shelled turtle insect and its prediction and analysis of quality marker (Q-Marker)[J]. Global Traditional Chinese Medicine, 2024, 17(5): 933-940.] DOI: 10.3969/j.issn.1674-1749.2024.05.035.

12. 周露, 段亚飞, 王奕航, 等. 血竭化学成分及其糖尿病肾脏疾病肾小管损伤保护作用评价[J]. 中国中药杂志, 2024, 49(5): 1249-1254. [Zhou L, Duan YF, Wang  YH, et al. Evaluation of chemical components of blood exhaustion and its protective effect on renal tubular injury in diabetic kidney disease[J]. China Journal of Chinese Materia Medica, 2024, 49(5): 1249-1254.] DOI: 10.19540/j.cnki.cjcmm.20231207.202.

13. 赵孟依, 毕成浩, 李梦娇, 等. 基于UPLC-Q-TOF/MS技术的龙生蛭胶囊成分快速分析[J]. 世界科学技术-中医药现代化, 2024, 26(8): 2144-2153. [Zhao  MY, Bi  CH, Li MJ, et al. Rapid analysis of components of dragon leech capsules based on UPLC-Q-TOF/MS technology[J]. Institutes of Science and Development, Chinese Academy of Sciences, 2024, 26(8): 2144-2153.] https://www.cnki.com.cn/Article/CJFDTotal-SJKX2024111200R.htm.

14. 刘佳敏, 黄海, 梁朋朋, 等. 基于UPLC-Q-TOF-MS结合网络药理学探讨黑逍遥散改善失眠大鼠学习记忆能力的药效物质基础及作用机制[J]. 中国实验方剂学杂志, 2024, 30(21): 19-30. [Liu JM, Huang H, Liang PP, et al. Based on UPLC-Q-TOF-MS combined with network pharmacology, the pharmacodynamic material basis and mechanism of Hei Xiaoyaosan in improving the learning and memory ability of insomnia rats were discussed[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30(21): 19-30.] DOI: 10.13422/j.cnki.syfjx.20250162.

15. 倪林君, 刘晓凤, 胡筱, 等. 虫类药土鳖虫化学成分研究进展[J]. 中华中医药学刊, 2024, 42(11): 170-176. [Ni LJ, Liu XF, Hu X, et al. Research progress on the chemical composition of insect medicine soil soft-shelled turtle insects[J]. Chinese Archives of Traditional Chinese Medicine, 2024, 42(11): 170-176.] DOI: 10.13193/j.issn.1673-7717.2024.11.033.

16. 刘金金, 刘艳梅, 梁慧, 等. 三化汤化学成分鉴定 [J]. 中成药, 2024, 46(4): 1195-1208. [Liu JJ, Liu  YM, Liang H, et al. Identification of chemical components of Sanhua decoction[J]. Chinese Traditional Patent Medicine, 2024, 46(4): 1195-1208.] DOI: 10.3969/j.issn.1001-1528.2024.04.021.

17. 李晓红. 骨碎补药材质量控制方法及药动学研究[D]. 沈阳: 沈阳药科大学, 2009. https://cdmd.cnki.com.cn/Article/CDMD-10163-2010171659.htm.

18. 杨宝. 没药化学成分的研究[D]. 南昌: 江西中医药大学, 2023. DOI: 10.27180/d.cnki.gjxzc.2023.000154.

19. 李海英, 贺鹏, 李文姣, 等. 补阳还五汤化学成分、药理作用研究进展及质量标志物(Q-Marker)预测[J]. 中草药, 2024, 55(13): 4575-4587. [Li HY, He P, Li WJ, et al. Research progress on chemical composition, pharmacological effects and prediction of quality markers (Q-Marker) of Buyang Huanwu decoction[J]. Chinese Herbal Medicines, 2024, 55(13): 4575-4587.] DOI: 10.7501/j.issn.0253-2670.2024.13.029.

20. 张方晴. 骨碎补总黄酮抗糖皮质激素性骨质疏松潜在有效成分及其分子机制的初步探讨[D]. 北京: 北京协和医学院, 2023. DOI: 10.27648/d.cnki.gzxhu.2023.000563.

21. 刘洪玲. 乳香挥发油化学成分的气相色谱-质谱分析 [J]. 时珍国医国药, 2009, 20(2): 370-371. [Liu HL. Gas chromatography-mass spectrometry analysis of the chemical composition of frankincense volatile oils[J]. Lishizhen Medicine and Materia Research, 2009, 20(2): 370-371.] DOI: 10.3969/j.issn.1008-0805.2009.02.060.

22. Zhao X, Wei J, Yang M. Simultaneous analysis of iridoid glycosides and anthraquinones in Morinda officinalis using UPLC-QQQ-MS/MS and UPLC-Q/TOF-MS(E) [J]. Molecules, 2018, 23(5): 1070.] DOI: 10.3390/molecules23051070.

23. 陈志. 基于基因测序和UPLC-Q-TOF/MS对四个鸡血藤属物种进行叶绿体基因组特征分析及化学成分分析[D]. 南昌: 江西中医药大学, 2023. DOI: 10.27180/d.cnki.gjxzc.2023.000624.

24. Yu H, Fu J, Guo H H, et al. Metabolites analysis of anti-myocardial ischemia active components of Saussurea involucrata based on gut microbiota-drug interaction[J]. Int J Mol Sci, 2022, 23(13): 7457. DOI: 10.3390/ijms23137457.

25. 张程瑞. 基于UPLC-Q-TOF-MS的喜树花果茎叶的靶向代谢组学分析[D]. 成都: 四川农业大学, 2020. DOI: 10.27345/d.cnki.gsnyu.2020.001038.

26. Lima K, Malmir M, Camoes SP, et al. Quality, safety and biological studies on Campylanthus glaber aerial parts[J]. Pharmaceuticals (Basel), 2023, 16(10): 1373. DOI: 10.3390/ph16101373.

27. Zuo MT, Gong MD, Ma X, et al. Sex differences in the in vivo exposure process of multiple components of gelsemium elegans in rats[J]. Metabolites, 2022, 13(1): 33. DOI: 10.3390/metabo13010033.

28. 刘元. 甲基异茜草素对破骨细胞分化调节机制的研究 [D]. 陕西延安: 延安大学, 2021. DOI: 10.27438/d.cnki.gyadu.2021.000246.

29. Chen ZH, Du DY, Fu YF, et al. Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis[J]. Mater Today Bio, 2023, 22: 100747. DOI: 10.1016/j.mtbio.2023.100747.

30. Abshirini M, Ilesanmi-Oyelere BL, Kruger MC. Potential modulatory mechanisms of action by long-chain polyunsaturated fatty  acids on bone cell and chondrocyte metabolism[J]. Prog Lipid Res, 2021, 83: 101113. DOI: 10.1016/j.plipres.2021.101113.

31. Wlodarska M, Luo C, Kolde R, et al. Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation[J]. Cell Host Microbe, 2017, 22(1): 25-37. DOI: 10.1016/j.chom.2017.06.007.

32. Liu D, Zhang S, Li S, et al. Indoleacrylic acid produced by Parabacteroides distasonis alleviates type 2 diabetes via activation of AhR to repair intestinal barrier[J]. BMC Biol, 2023, 21(1): 90. DOI: 10.1186/s12915-023-01578-2.

33. Moon SM, Lee SA, Hong JH, et al. Oleamide suppresses inflammatory responses in LPS-induced RAW264.7 murine macrophages and alleviates paw edema in a carrageenan-induced inflammatory rat model[J]. Int Immunopharmacol, 2018, 56: 179-185. DOI: 10.1016/j.intimp.2018.01.032.

34. 徐珒昭, 汤梦琪, 徐境含, 等. 焦谷氨酸对高盐饮食小鼠肠道健康及肠道菌群的作用[J]. 食品与发酵工业, 2021, 47(2): 102-108. [Xu JZ, Tang MQ, Xu JH, et al. Effect of pyroglutamic acid on intestinal health and intestinal microbiota in mice on high-salt diet[J]. Food and Fermentation Industries, 2021, 47(2): 102-108.] DOI: 10.13995/j.cnki.11-1802/ts.024997.

35. 李焱. 焦谷氨酸钙的抗骨质疏松、抗阿尔茨海默症及抗疲劳活性初步研究[D]. 山东青岛: 青岛大学, 2020. DOI: 10.27262/d.cnki.gqdau.2020.001866.

36. 杨丽平, 杜茂波, 马放, 等. 基于LC/MS技术的益气清热膏冻干粉及含药血清成分鉴定[J]. 中华中医药杂志, 2022, 37(8): 4725-4730. [Yang LP, Du MB, Ma F, et al. Identification of lyophilized powder and medicated serum components of Yiqi Qingheat cream based on LC/MS technology[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2022, 37(8): 4725-4730.] https://www.cnki.com.cn/Article/CJFDTotal-BXYY202208100.htm.

Popular papers
Last 6 months